News | October 28, 2021
Indian Pharma Market witnesses rise in volumes and prices in September.
Acute therapies continue to report strong growth compared to chronic ones.
Acute therapies continue to report strong growth compared to chronic ones.
Kymriah, the first-ever FDA-approved CAR-T cell therapy, is currently available in 30 countries in one or more indications
First anticipated spinout from the alliance, Circle Therapeutics, to develop novel muscle stem cell therapies for a variety of skeletal muscle disorders
The revised deal involves a cash consideration only as against the earlier proposal of cash and equity
The Pune centre expands its presence beyond Bangalore and Hyderabad
Tezepelumab has been granted Orphan Drug Designation (ODD) in the US by the U.S. Food and Drug Administration (FDA) for the treatment of eosinophilic esophagitis (EoE)
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
The rates for over 400 procedures were revised
The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families
Droxidopa capsules, 100 mg, 200 mg, and 300 mg is a generic equivalent of Northera capsules, 100 mg, 200 mg, and 300 mg, of Lundbeck NA
Subscribe To Our Newsletter & Stay Updated
